Articles

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy
Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
Cancer Sciences Unit, Southampton Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK;Division of Hematology, University of Siena, Siena, Italy
Department of Hematology Oncology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy
Clinica Ematologica, DAME, University of Udine, Udine, Italy
Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy
Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy
Division of Hematology, Azienda Ospedaliera Universitaria Policlinico-OVE, Catania, Italy
Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy
Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy
Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza and University of Turin, Turin, Italy
Section of Hematology, Department of Medicine, University of Verona, Verona, Italy
Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy
Fondazione Policlinico Universitario A. Gemelli, Rome, Italy
Department of Hematology, Spedali Civili, Brescia, Italy
Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK
Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK
Centre for Cancer Research and Cell Biology (CCRCB), Queen’s University Belfast, Belfast, Northern Ireland, UK
Department of Haematology, Beaumont Hospital, Dublin, Ireland
Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK
Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland
Department of Hematology, Tor Vergata University, Rome, Italy
Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy
Department of Health Sciences, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy
Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy
Department of Pathology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy
Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK
Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2019.219550